Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

59 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL

NCT02987400

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • UK Graz: Universitätsklinik für Innere Medizin; Klinische Abteilung für Hämatologie Graz, Austria
  • Medizinische Universität Innsbruck Univ.-Klinik für Innere Medizin V Hämatologie und Onkologie Innsbruck, Austria
  • Kepler Universitätsklinikum Linz, Med Campus III.,Univ.-Klinik für Hämatologie und Internistische Onkologie Linz, Austria
  • Universitätsklinik für Innere Med. III, PMU Salzburg Salzburg, Austria
View Trial Details
Completed

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

NCT02669017

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

NCT02343536

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

NCT01307267

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • City of Hope Duarte, California, United States
  • UC San Diego Moores Cancer Center-Investigational Drug Services La Jolla, California, United States
  • UC San Diego Medical Center-La Jolla (Jacobs Medical Center/Thornton Hospital) La Jolla, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 42 locations
View Trial Details
Completed

To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL

NCT02624492

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Jessa Ziekenhuis - Campus Virga Jesse Hasselt, Belgium
  • Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
  • Istituto Clinico Humanitas Rozzano (MI), Italy
  • A. O. S. Maria della Misericordia Udine, Italy
View Trial Details
Completed

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

NCT02208037

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +35 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details
Completed

Lenalidomide and R-CHOP in B-cell Lymphoma

NCT00901615

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • CHU de Dijon Dijon, France
  • CHRU Lille Lille, France
  • CHU Lyon Sud Pierre-Bénite, France
  • Centre Henri Becquerel Rouen, France
View Trial Details

Related conditions